In type 2 diabetes (T2D), miR-146a acts as a molecular switch of insulin signaling and inflammation, and its dysregulation promotes insulin resistance and complications such as nephropathy, neuropathy, cardiovascular disease, and retinopathy [40,41,42]. This evidence concerns the gene INS and cardiovascular disorder.